Piermont Capital Management Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$505,000
-35.5%
165,569
-2.1%
0.12%
-37.8%
Q3 2016$783,000
-12.5%
169,079
+9.4%
0.18%
-20.3%
Q2 2016$895,000
+83.8%
154,619
+91.9%
0.23%
+49.7%
Q1 2016$487,000
-35.8%
80,569
+66.4%
0.16%
-32.9%
Q1 2015$759,000
+54.9%
48,430
+50.4%
0.23%
+32.8%
Q4 2014$490,000
+87.7%
32,210
+33.3%
0.17%
+72.3%
Q3 2014$261,00024,1700.10%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders